Intellia Therapeutics, Inc. is a clinical-stage gene editing company focused on developing CRISPR-based therapies to treat severe diseases. The company serves patients with conditions such as hereditary angioedema and transthyretin amyloidosis.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.